Connect with us

International

Final preparations underway for NASA’s Moon rocket launch

Photo: Jim Watson / AFP

| By AFP | Lucie Aubourg |

After two failed attempts this summer, NASA was busy Monday completing final preparations for the launch of its new mega Moon rocket, now scheduled for early Wednesday from Florida. 

The Artemis 1 mission, a test flight without astronauts, represents the first step in the US space agency’s plan to build a lasting presence on the Moon, and taking lessons from there to prepare for a future voyage to Mars.

Named after the sister of Apollo in Greek mythology, the new space program comes 50 years after humans last set foot on lunar soil.

The first launch of the Space Launch System rocket, the most powerful ever designed by NASA, is set for Wednesday at 1:04 am local time (0604 GMT), with a possible launch window of two hours.

Advertisement
20260101_dengue_cubeta_728x90
previous arrow
next arrow

Countdown has already begun at the storied Kennedy Space Center, where the orange and white behemoth awaits its maiden flight.

The takeoff is scheduled less than a week after the passage of Hurricane Nicole, which the rocket endured outside on its launch pad.

For now, officials are evaluating the risk associated with hurricane damage to a thin strip of caulk-like material called RTV, which encircles the Orion crew capsule atop the rocket, and makes it more aerodynamic.

Teams are looking at whether the RTV could shake loose during launch and pose problems.

Two fallback dates are possible if needed, on November 19 and 25.

Advertisement
20260101_dengue_cubeta_728x90
previous arrow
next arrow

But Mike Sarafin, in charge of the Artemis 1 mission, was optimistic Sunday evening. “I feel good headed into this attempt,” he said.

Far side of Moon

The weather promises to be mild, with a 90 percent chance of favorable conditions during the launch window.

At the end of September, the rocket had to be wheeled back to its assembly building to be sheltered from another hurricane, Ian, postponing the mission by several weeks.

Before these weather setbacks, two launch attempts had to be canceled for technical reasons.

The first failure was related to a faulty sensor, and the second to a fuel leak when filling the rocket’s tanks. It runs on ultra-cold, ultra-volatile liquid oxygen and hydrogen.

Advertisement
20260101_dengue_cubeta_728x90
previous arrow
next arrow

NASA has since replaced a seal and modified its procedures to avoid thermal shock as much as possible, and succeeded in a tank filling test in late September. 

These filling operations are now due to begin Tuesday afternoon, under the orders of Charlie Blackwell-Thompson, NASA’s first female launch director.

About 100,000 people are expected on the coast to watch the launch, with the rocket promising to light up the night sky.

The Orion capsule will be lifted by two boosters and four powerful engines under the core stage, which will detach after only a few minutes.

After a final push from the upper stage, the capsule will be well on its way, taking several days to reach its destination.

Advertisement
20260101_dengue_cubeta_728x90
previous arrow
next arrow

Rather than landing on the Moon, it will assume a distant orbit, venturing 40,000 miles (64,000 kilometers) beyond Earth’s natural satellite — further than any other habitable spacecraft so far.

Finally, Orion will embark on the return leg of its journey. When passing through the atmosphere, the capsule’s heat shield will need to withstand a temperature half as hot as the Sun’s surface.

If takeoff happens Wednesday, the mission would last 25 and a half days in all, with a splashdown in the Pacific Ocean on December 11.

NASA is banking on a successful mission after developing the SLS rocket for more than a decade. It will have invested more than $90 billion in its new lunar program by the end of 2025, according to a public audit.

Artemis 2 will be almost a replay of the first mission, albeit with astronauts, in 2024. 

Advertisement
20260101_dengue_cubeta_728x90
previous arrow
next arrow

Boots on the ground should happen during Artemis 3, no sooner than 2025, with the crew set to include the first woman and first person of color on the Moon.

NASA then wants to launch around one mission per year and build a lunar space station called Gateway. There, humanity must learn to live in deep space and develop the technologies necessary for a round trip to Mars, perhaps in the late 2030s.

Continue Reading
Advertisement
20260101_dengue_balde_300x250

International

Nicolás Maduro’s Son Calls U.S. Trial Against His Father and Cilia Flores “Unjust”

Venezuelan lawmaker Nicolás Maduro Guerra on Wednesday described as “unjust” the legal proceedings in the United States against his father, ousted Venezuelan President Nicolás Maduro, and his wife, Cilia Flores, following their capture in Caracas on January 3 by U.S. forces.

“Faced with the unjust trial taking place today, the people raised their voices with a single demand: We demand the immediate release of President Nicolás Maduro and the First Lady,” Maduro Guerra wrote on his Instagram account.

The lawmaker attended a rally in Caracas where supporters of the ruling United Socialist Party of Venezuela (PSUV)gathered to show support for the former president, who faces charges in the United States including conspiracy to commit narco-terrorism and cocaine importation. Flores is accused of crimes related to drug trafficking and weapons possession.

The event was also attended by PSUV Vice President for Mobilizations and Events Nahum Fernández and Caracas Mayor Carmen Meléndez, according to photos shared by Maduro’s son.

The third hearing in the case against Maduro and Flores concluded Wednesday at a federal court in New York after lasting only about 18 minutes. During the hearing, the judge preliminarily set June 2027 as the expected start date for the trial.

Advertisement

20260101_dengue_cubeta_728x90

previous arrow
next arrow

One of the main arguments from the defense will focus on immunity. Maduro’s lead attorney, Barry Pollack, who has also represented WikiLeaks founder Julian Assange, said the defense plans to request immunity for both defendants, arguing that Maduro was serving as head of state and Flores as first lady at the time of their detention.

Both Maduro and Flores pleaded not guilty during their first court appearance in New York on January 5.

Meanwhile, Venezuela’s interim president Delcy Rodríguez, who assumed power after Maduro’s capture, has not yet commented on Wednesday’s hearing in the United States.

Continue Reading

International

Mexico Files 20 Complaints in U.S. Over Deaths of 17 Citizens During ICE Operations

The Mexican government announced that it has filed 20 legal complaints across different jurisdictions in the United States seeking investigations into the deaths of 17 Mexican citizens who died since May 2025 during immigration enforcement operations or while in the custody of the U.S. Immigration and Customs Enforcement (ICE).

Mexico’s Secretariat of Foreign Affairs (SRE) reported that the complaints were submitted on July 13 by Mexico’s ambassador to the United States, Roberto Lazzeri. Of the total, eight cases were filed with state prosecutors’ offices and 12 with county prosecutors’ offices in Arizona, California, Florida, Georgia, Illinois, Louisiana, Missouri, and Texas.

According to the Mexican government, the legal actions seek to clarify the circumstances surrounding each death and determine whether any immigration authorities may bear responsibility.

During meetings with representatives from the Department of Homeland Security (DHS) and ICE, Ambassador Lazzeri expressed Mexico’s concerns over conditions in immigration detention centers, including privately operated facilities, and requested thorough investigations into every case.

In addition to the complaints filed in the United States, Mexico’s Foreign Affairs Ministry sent a communication to United Nations High Commissioner for Human Rights Volker Türk, informing him of the deaths and requesting that the UN gather information, assess the situation under international human rights standards, and issue recommendations to prevent similar incidents.

Advertisement

20260101_dengue_cubeta_728x90

previous arrow
next arrow

The SRE also stated that Mexico’s consular network continues to provide support to the families of the deceased citizens, including legal assistance, help with repatriation of remains, and other procedures requested by relatives.

The announcement comes after the death of Lorenzo Salgado Araújo, a Mexican citizen who died after being shot by ICE agents during an immigration operation in Texas. The case has gained additional attention after a federal judge in Houston ordered a halt to the deportation of José Trinidad Rojas Pliego, considered a key witness in the incident.

Mexican authorities reiterated that they will continue using all available legal and diplomatic mechanisms to monitor the investigations and defend the rights of Mexican citizens in U.S. territory.

Continue Reading

International

India Approves New Dengue Vaccine as Global Cases Continue to Rise

India has approved a new dengue vaccine as health authorities seek to strengthen prevention efforts against a mosquito-borne viral disease that affects millions of people worldwide every year.

According to the World Health Organization (WHO), half of the global population is currently at risk of contracting dengue, which causes between 100 million and 400 million infections annually.

Since 2021, India has recorded more than one million dengue cases, including at least 1,500 deaths.

The virus can cause high fever, severe headaches, muscle pain, nausea, skin rashes and, in rare cases, internal bleeding and death.

The vaccine, authorized by India’s Central Drugs Standard Control Organization (CDSCO), was developed by Japanese pharmaceutical company Takeda. The Indian Health Ministry said the vaccine is recommended in two doses for people between 4 and 60 years old.

The treatment has already been approved by health authorities in around 40 countries worldwide.

Meanwhile, Indian pharmaceutical company Panacea Biotec has begun the final phase of clinical trials for a single-dose dengue vaccine, aiming to provide another prevention option against the disease.

Brazil recently announced the suspension of the use of another single-dose dengue vaccine developed in the country after two suspected deaths were reported.

Continue Reading
Advertisement
20260101_dengue_balde_300x250

Trending

Central News